Biotech continues to outperform the broader markets, because doing so did through the first 1 / 2 of 2011. You see, despite international and domestic evens on the political and policy fronts, the NASDAQ Biotechnology sector outperformed t…
Quote saved.
Login to quote this blog
Failed to save quote. Please try again later.
You cannot quote because this article is private.